Research
Pneumococcal vaccination and risk of myocardial infarction
François Lamontagne, Marie-Pierre Garant, Jean-Christophe Carvalho, Luc Lanthier, Marek Smieja and Danielle Pilon
CMAJ October 07, 2008 179 (8) 773-777; DOI: https://doi.org/10.1503/cmaj.070221
François Lamontagne MD MSc
Marie-Pierre Garant PhD
Jean-Christophe Carvalho MD
Luc Lanthier MD MSc
Marek Smieja MD PhD
In this issue
Article tools
Respond to this article
Pneumococcal vaccination and risk of myocardial infarction
François Lamontagne, Marie-Pierre Garant, Jean-Christophe Carvalho, Luc Lanthier, Marek Smieja, Danielle Pilon
CMAJ Oct 2008, 179 (8) 773-777; DOI: 10.1503/cmaj.070221
Jump to section
Related Articles
Cited By...
- Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions
- Does pneumococcal vaccination prevent myocardial infarction and stroke in elderly adults?
- Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis
- Vaccine for Atherosclerosis
- Influenza Vaccination and Major Adverse Vascular Events in High-Risk Patients
- Pneumococcal vaccination and risk of acute coronary syndromes in patients with pneumonia: population-based cohort study
- Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
- Adult immunization: Last on the list
- Immunisation chez l'adulte: Derniere de la liste
- Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study
- Pneumococcal vaccination and myocardial infarction
- Pneumococcal vaccination and myocardial infarction
- Pneumococcal vaccination and myocardial infarction
- Acute infections, vaccination and prevention of cardiovascular disease